Lunch brief: Unlock the power of NAD+ with boosting precursors, Recent studies and developments on NAD+ featuring NMN and reduced NMN (NMNH) (Effepharm)

NAD (nicotinamide adenine dinucleotide) is a vital coenzyme found in every living cell and a critical molecule at the core of cellular metabolism, aging and health. This presentation will introduce the science of NAD+, with a focus on the most recent groundbreaking studies highlighting two powerful NAD+ precursors: NMN (nicotinamide mononucleotide) and its reduced form, NMNH. These compounds are rapidly gaining attention for their remarkable potential to boost NAD+ levels and promote cellular vitality.

Learn about recent findings from human clinical studies from a speaker who will translate complex scientific data into accessible language for brand formulators and marketers. Emphasis will be placed on demonstrating the efficacy and safety of these innovative ingredients, fostering a deeper understanding of their benefits and illuminating new product development opportunities.

Speakers:

• Richard H. Kaszynski, M.D., Ph.D., Co-Founder and director, Stanford Solutions, Trustee, the ASHINAGA organization

If you are interested in attending, please sign-up here!